Table 3.
The number and proportion of associated* prescriptions for individuals with an incident ED diagnosis
| Antidepressants | Anxiolytic/hypnotics | Antipsychotics | ||||
| Individuals (n) | Proportion† (%, 95% CI) |
Individuals (n) | Proportion† (%, 95% CI) |
Individuals (n) | Proportion† (%, 95% CI) |
|
| Sex | ||||||
| Male | 78 | 17.8 (14.5 to 21.6) | 17 | 3.9 (2.4 to 6.1) | 14 | 3.2 (1.9 to 5.3) |
| Female | 1176 | 27.1 (25.8 to 28.5) | 139 | 3.2 (2.7 to 3.8) | 70 | 1.6 (1.3 to 2.0) |
| Age | ||||||
| 11 to 15 | 128 | 9.0 (7.6 to 10.6) | 21 | 1.5 (1.0 to 2.2) | 22 | 1.5 (1.0 to 2.3) |
| 16 to 20 | 687 | 29.3 (27.5 to 31.1) | 85 | 3.6 (2.9 to 4.5) | 42 | 1.8 (1.3 to 2.4) |
| 21 to 24 | 439 | 43.8 (40.8 to 46.9) | 50 | 5.0 (3.8 to 6.5) | 20 | 2.0 (1.3 to 3.1) |
| Deprivation | ||||||
| 1 (least) | 311 | 25.9 (23.5 to 28.4) | 37 | 3.1 (2.2 to 4.2) | 19 | 1.6 (1.0 to 2.5) |
| 2 | 295 | 28.3 (25.6 to 31.1) | 30 | 2.9 (2.0 to 4.1) | 24 | 2.3 (1.5 to 3.4) |
| 3 | 220 | 24.9 (22.1 to 27.8) | 28 | 3.2 (2.2 to 4.5) | 13 | 1.5 (0.9 to 2.5) |
| 4 | 229 | 24.0 (21.4 to 26.8) | 27 | 2.8 (2.0 to 4.1) | 11 | 1.2 (0.6 to 2.1) |
| 5 (most) | 197 | 28.5 (25.3 to 32.0) | 33 | 4.8 (3.4 to 6.6) | 17 | 2.5 (1.5 to 3.9) |
| Year | ||||||
| 2004 | 105 | 22.1 (18.6 to 26.1) | 8 | 1.7 (0.9 to 3.3) | 3 | 0.6 (0.2 to 1.8) |
| 2005 | 112 | 24.2 (20.6 to 28.4) | 10 | 2.2 (1.2 to 3.9) | 5 | 1.1 (0.5 to 2.5) |
| 2006 | 112 | 22.8 (19.3 to 26.7) | 16 | 3.3 (2.0 to 5.2) | 10 | 2.0 (1.1 to 3.7) |
| 2007 | 133 | 25.3 (21.8 to 29.2) | 19 | 3.6 (2.3 to 5.6) | 4 | 0.8 (0.3 to 1.9) |
| 2008 | 115 | 23.0 (19.6 to 26.9) | 15 | 3.0 (1.8 to 4.9) | 8 | 1.6 (0.8 to 3.1) |
| 2009 | 125 | 26.2 (22.4 to 30.3) | 12 | 2.5 (1.4 to 4.3) | 5 | 1.0 (0.4 to 2.4) |
| 2010 | 105 | 25.7 (21.7 to 30.2) | 21 | 5.1 (3.4 to 7.7) | 12 | 2.9 (1.7 to 5.1) |
| 2011 | 127 | 30.3 (26.1 to 34.9) | 17 | 4.1 (2.5 to 6.4) | 9 | 2.1 (1.1 to 4.0) |
| 2012 | 115 | 29.2 (24.9 to 33.9) | 14 | 3.6 (2.1 to 5.9) | 8 | 2.0 (1.0 to 4.0) |
| 2013 | 123 | 34.5 (29.7 to 39.5) | 18 | 5.0 (3.2 to 7.8) | 12 | 3.4 (1.9 to 5.8) |
| 2014 | 82 | 30.8 (25.6 to 36.6) | 6 | 2.3 (1.0 to 4.8) | 8 | 3.0 (1.5 to 5.8) |
| ED subtype | ||||||
| AN | 290 | 22.2 (20.0 to 24.5) | 30 | 2.3 (1.6 to 3.3) | 26 | 2.0 (1.4 to 2.9) |
| BN | 315 | 28.5 (25.9 to 31.3) | 35 | 3.2 (2.3 to 4.4) | 14 | 1.3 (0.8 to 2.1) |
| EDNOS | 649 | 20.6 (19.2 to 22.1) | 91 | 2.9 (2.4 to 3.5) | 44 | 1.4 (1.0 to 1.9) |
Total study Population=1 135 038 individuals.
*Associated prescription was defined as 6 months before or 12 months after an ED diagnosis.
† Proportion of individuals with an incident ED diagnosis (n=4775).
AN, anorexia nervosa; BN, bulimia nervosa; ED, eating disorder; EDNOS, ED, not otherwise specified.